Coffee: The magical bean for liver diseases (Q33716189)

28 July 2017

1 reference

title

Coffee: The magical bean for liver diseases (English)

1 reference

28 July 2017

Ryan D Heath

1

1 reference

28 July 2017

Mihir Brahmbhatt

2

1 reference

28 July 2017

Asli C Tahan

3

1 reference

28 July 2017

Jamal A Ibdah

4

1 reference

28 July 2017

Veysel Tahan

5

1 reference

28 July 2017

publication date

1 May 2017

1 reference

World Journal of Hepatology

28 July 2017

published in

1 reference

28 July 2017

volume

9

1 reference

28 July 2017

issue

15

1 reference

28 July 2017

page(s)

689-696

1 reference

Coffee Intake and Liver Enzyme Association in Korean Immigrants and Japanese: A Comprehensive Cross-Sectional Study

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee Drinking Is Widespread in the United States, but Usual Intake Varies by Key Demographic and Lifestyle Factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee consumption and NAFLD: a community based study on 1223 subjects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Caffeine inhibits hepatitis C virus replication in vitro

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Is it time to write a prescription for coffee? Coffee and liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Increased caffeine consumption is associated with reduced hepatic fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee and liver diseases.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee intake and mortality from liver cirrhosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Epidemiological evidence on coffee and digestive tract cancers: a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States

21 June 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Unexpected effects of coffee consumption on liver enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Coffee consumption and serum aminotransferases in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Coffee, caffeine, and the risk of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Does coffee protect against liver cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II).

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Deaths: leading causes for 2010.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5440772

Association of caffeine intake and histological features of chronic hepatitis C

30 October 2018

1 reference

https://api.crossref.org/works/10.4254/WJH.V9.I15.689

Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice

21 January 2018

1 reference

12 December 2020

The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography

1 reference

12 December 2020

Association of Coffee and Caffeine Consumption With Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Degree of Hepatic Fibrosis

1 reference

12 December 2020

"Could a cup of coffee a day keep the liver doctor away?": One cup or two or more cups of coffee per day reduces the risk of death from cirrhosis

1 reference

12 December 2020

Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men

1 reference

12 December 2020

Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers

1 reference

12 December 2020

The Tromsø Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population

1 reference

12 December 2020

Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V9.I15.689

1 reference

28 July 2017

1 reference

28 July 2017

1 reference